Testing a new drug with clot removal for severe back-of-the-brain stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial checks if adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency clot removal can improve recovery for people with a severe stroke affecting the back part of the brain (posterior circulation). It is for patients who need urgent treatment within 24 hours of symptom onset.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a sudden blockage of the main artery in the back part of your brain (basilar artery)
- Your stroke is severe enough that you have a score of 10 or higher on the NIH stroke scale
- You are able to start the clot-removal procedure within 24 hours of the first symptoms
- You do not have a bleeding disorder, active infection, or known allergies to the study drug or contrast dye
- You are not pregnant or planning pregnancy in the next 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug tocilizumab (which blocks a protein called interleukin-6) can help prevent further strokes in people who have had a stroke or mini-stroke due to a narrowed artery inside the skull. If you are eligible, you would receive either tocilizumab or a placebo to see if it reduces your risk of another stroke.
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
This trial tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after a successful mechanical clot removal can improve recovery for people with a certain type of stroke. The goal is to see if it safely helps clear any remaining tiny clots and reduces disability.
This study looks at inflammation signals in the body and in brain MRI scans after treatment to reopen a blocked brain artery. It may help researchers understand who benefits most from different “reperfusion” treatments like clot-busting medicine or procedures.
This trial tests if a procedure to remove a blood clot from the main artery in the back of the brain (basilar artery) can help people who have a large stroke. The procedure is done within 24 hours of symptom onset, and researchers want to see if it can reduce disability.
This trial tests a new medicine (glenzocimab) given along with standard clot-removal procedure for people who had a stroke with a large area of brain damage. The goal is to see if the medicine helps improve recovery.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.